KINNATE BIOPHARMA INC(NASDAQ:KNTE) stock News

KNTE Latest News, Press Relases and Analysis

All

Press Releases

a year ago - By: XOMA Corporation - Mentions: XOMA

XOMA Corporation Announces Closing of Tender Offer

a year ago - By: Brodsky & Smith LLC - Mentions: AGTI LABP FUSN ABBV ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN), Kinnate Biopharma Inc. (Nasdaq – KNTE)

2 years ago - By: Rowley Law PLLC

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kinnate Biopharma Inc.

a year ago - By: XOMA Corporation - Mentions: XOMA

XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.

a year ago - By: Brodsky & Smith LLC - Mentions: FUSN FREE SCTL AZN ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Pharmaceuticals Inc. (Nasdaq - FUSN), Whole Earth Brands, Inc. (Nasdaq – FREE), Kinnate Biopharma Inc. (Nasdaq – KNTE), Societal CDMO Check Corp. (Nasdaq –

a year ago - By: Kahn Swick & Foti, LLC

KINNATE BIOPHARMA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kinnate Biopharma Inc. - KNTE

a year ago - By: Brodsky & Smith LLC - Mentions: FREE XOMA SCTL CALB ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Whole Earth Brands, Inc. (Nasdaq – FREE), Kinnate Biopharma Inc. (Nasdaq – KNTE), Societal CDMO Check Corp. (Nasdaq – SCTL), California BanCorp (Nasdaq – CALB)

2 years ago - By: Pierre Fabre

Kinnate Biopharma Inc. vende su inhibidor Pan-RAF en fase de investigación, exarafenib, a Pierre Fabre Laboratories

2 years ago - By: Pierre Fabre

Kinnate Biopharma Inc. verkauft seinen in der Entwicklung befindlichen Pan-RAF-Inhibitor, Exarafenib an Pierre Fabre Laboratories

2 years ago - By: Seeking Alpha

Kinnate Biopharma sells rights of exarafenib to Pierre Fabre laboratories (NASDAQ:KNTE)

2 years ago - By: Pierre Fabre

Kinnate Biopharma Inc. vend son inhibiteur pan-RAF expérimental, l'exarafenib, aux Laboratoires Pierre Fabre

2 years ago - By: Pierre Fabre

Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories

2 years ago - By: Kinnate Biopharma; Pierre Fabre Laboratories

Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories

2 years ago - By: Kinnate Biopharma; Pierre Fabre Laboratories

Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories

2 years ago - By: Brodsky & Smith LLC - Mentions: AVRO FREE CALB

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AVROBIO, Inc. (Nasdaq – AVRO), Whole Earth Brands, Inc. (Nasdaq – FREE), Kinnate Biopharma Inc. (Nasdaq – KNTE), California BanCorp (Nasdaq – CALB)

2 years ago - By: Brodsky & Smith LLC - Mentions: VZIO HRT CALB XOMA ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: VIZIO Holding Corp. (NYSE - VZIO), HireRight Holdings Corporation (NYSE – HRT), Kinnate Biopharma Inc. (Nasdaq – KNTE), California BanCorp (Nasdaq – CALB)

2 years ago - By: Kahn Swick & Foti, LLC

KINNATE BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kinnate Biopharma Inc. - KNTE

2 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Kinnate Biopharma Inc. has obtained a Fair Price in its transaction with XOMA

2 years ago - By: Benzinga - Mentions: XOMA

Biotech Royalty Aggregator XOMA To Acquire Small Cancer-Drug Developer Kinnate Biopharma

2 years ago - By: Brodsky & Smith LLC - Mentions: HRT AVRO CALB

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HireRight Holdings Corporation (NYSE – HRT), Kinnate Biopharma Inc. (Nasdaq – KNTE), AVROBIO, Inc. (Nasdaq – AVRO), California BanCorp (Nasdaq – CALB)

2 years ago - By: NEW YORK

KNTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Kinnate Biopharma Inc. Is Fair to Shareholders

2 years ago - By: Seeking Alpha - Mentions: XOMA

Xoma to acquire Kinnate Biopharma (NASDAQ:XOMA)

2 years ago - By: Kinnate Biopharma

Kinnate Biopharma Inc. Enters into Agreement to be Acquired by XOMA Corporation for Between $2.3352 and $2.5879 Per Share in Cash, Plus One Contingent Value Right per Share

2 years ago - By: Kinnate Biopharma

Kinnate Biopharma Inc. Enters into Agreement to be Acquired by XOMA Corporation for Between $2.3352 and $2.5879 Per Share in Cash, Plus One Contingent Value Right per Share

2 years ago - By: XOMA Corporation - Mentions: XOMA

XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right

2 years ago - By: Benzinga - Mentions: BTDR IHRT VWE SXTP ...

Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

2 years ago - By: Kinnate Biopharma

Kinnate Biopharma Inc. Reports Third Quarter 2023 Financial Results and Recent Corporate Updates

2 years ago - By: Kinnate Biopharma

KINNATE BIOPHARMA INC (KNTE) Stock News

KNTE Latest News, Press Relases and Analysis